NCT05775159 2026-02-18
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
AstraZeneca
Phase 2 Recruiting
AstraZeneca
Merck Sharp & Dohme LLC
Novo Nordisk A/S
e-Therapeutics PLC